Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Benzonatate (/bɛnˈzoʊnəteɪt/), sold under the brand name Tessalon among others, is a medication that is used for the symptomatic relief of cough. Benzonatate is taken by mouth. Effects generally begin within 20 minutes and last between 3 and 8 hours.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Benzonatate. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cough local effects medication united states procaine tetracaine anesthetic anesthetics mouth medical reported symptoms capsule children overdose available capsules death
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Benzonatate | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Benzonatate | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Benzonatate | ATC code | R05DB01 (WHO) | 1.00 | infobox |
| Benzonatate | CAS Number | 32760-16-0 Y | 1.00 | infobox |
| Benzonatate | ChEBI | CHEBI:3032 Y | 1.00 | infobox |
| Benzonatate | ChEMBL | ChEMBL1374379 Y | 1.00 | infobox |
| Benzonatate | ChemSpider | 7413 Y | 1.00 | infobox |
| Benzonatate | CompTox Dashboard (EPA) | DTXSID9022655 | 1.00 | infobox |
| Benzonatate | Drug class | Antitussives; Local anesthetics; Sodium channel blockers | 1.00 | infobox |
| Benzonatate | DrugBank | DB00868 Y | 1.00 | infobox |
| Benzonatate | Duration of action | 3–8 hours | 1.00 | infobox |
| Benzonatate | ECHA InfoCard | 100.002.904 | 1.00 | infobox |
| Benzonatate | Elimination half-life | 1 hour[unreliable medical source?] | 1.00 | infobox |
| Benzonatate | Formula | C30H53NO11 | 1.00 | infobox |
| Benzonatate | IUPHAR/BPS | 7611 | 1.00 | infobox |
| Benzonatate | KEGG | D00242 Y | 1.00 | infobox |
| Benzonatate | Legal status | US: ℞-only | 1.00 | infobox |
| Benzonatate | License data | US DailyMed: Benzonatate | 1.00 | infobox |
| Benzonatate | MedlinePlus | a682640 | 1.00 | infobox |
| Benzonatate | Molar mass | 603.750 g·mol−1 | 1.00 | infobox |
| Benzonatate | Onset of action | 15–20 minutes | 1.00 | infobox |
| Benzonatate | Other names | Benzononatine; Egyt-13; KM-65 | 1.00 | infobox |
| Benzonatate | PubChem CID | 7699 | 1.00 | infobox |
| Benzonatate | Routes of administration | By mouth | 1.00 | infobox |
| Benzonatate | Trade names | Tessalon, others | 1.00 | infobox |
| Benzonatate | UNII | 5P4DHS6ENR | 1.00 | infobox |
| Benzonatate | is a | local anesthetic and voltage-gated sodium channel blocker | 0.90 | text |
| Benzonatate | is a | potent voltage-gated sodium channel blocker | 0.90 | text |
| Benzonatate | is a | mixture of n-ethoxy compounds | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.